Stock Price Targets and Analyst Ratings All RatingsU.S.U.K.CanadianUpgradesDowngradesInitiationsPrice Target ChangesMore Date out of range. Reporting Date Country USA (NYSE & NASDAQ) United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrials Medical Miscellaneous Multi-Sector Conglomerates Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap All Ratings Strong Buy Buy Hold Sell Rating By Symbol By Time Added Sort Order Export to Excel CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetailsALECAlectorDowngraded byCowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy rating $1.61-49.8%HoldALECAlectorDowngraded byCantor FitzgeraldSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingPete StavropoulosSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$1.61-49.8%Overweight ➝ NeutralALECAlectorDowngraded byWilliam BlairSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingMyles MinterSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$1.61-49.8%Outperform ➝ Market PerformALECAlectorDowngraded byTD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingYaron WerberSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$1.61-49.8%Buy ➝ HoldALECAlectorDowngraded byBTIG ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingThomas ShraderSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$1.61-49.8%Buy ➝ NeutralARCTArcturus TherapeuticsDowngraded byGuggenheimSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSeamus FernandezSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$11.54-50.2%Buy ➝ NeutralAVDLAvadel PharmaceuticalsDowngraded byNeedham & Company LLCSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAmi FadiaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$18.53+3.7%Buy ➝ HoldAVDLAvadel PharmaceuticalsDowngraded byJefferies Financial GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAndrew TsaiSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$18.53+3.7%$22.00 ➝ $20.00Buy ➝ HoldBIOXBioceres Crop SolutionsDowngraded byOppenheimerSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingKristen OwenSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$1.91+8.5%Outperform ➝ Market PerformGGALGrupo Financiero GaliciaDowngraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDomingos FalavinaSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$33.02+2.8%$74.00 ➝ $46.00Overweight ➝ NeutralGPNGlobal PaymentsDowngraded byKeyCorpSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingAlex MarkgraffSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$85.73-2.2%Overweight ➝ Sector WeightHPQHPDowngraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSamik ChatterjeeSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$27.66-1.8%$30.00Overweight ➝ NeutralSUPVGrupo SupervielleDowngraded byJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingYuri FernandesSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating$6.04-3.0%$15.00 ➝ $5.00Neutral ➝ UnderweightAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 04:56 PM ET. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
